Thomson Reuters, CHDI Partner on Tools for Huntington's Disease | GenomeWeb

NEW YORK (GenomeWeb News) – Thomson Reuters' Intellectual Property & Science business announced a deal with the CHDI Foundation to develop systems biology tools for Huntington's disease.

The terms of the collaboration, announced on Thursday, include the reconstruction and analysis of causal networks that underlie HD mechanisms, and building a comprehensive collection of HD pathology pathway maps.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.